Alice Oliffson Kamphorst

16PUBLICATIONS
170CO-AUTHORS
Predictive and prognostic markersInnate immunityHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 16, 2026
Dendritic cells control tertiary lymphoid structure development and maintenance in cancer.

|Jan 27, 2026
Humoral IgG1 responses to tumor antigens underpin clinical outcomes in immune checkpoint blockade.

Edgar Gonzalez-Kozlova, Robert Sweeney, Igor Figueiredo

|Nov 18, 2025
Guidelines for T cell nomenclature.

David Masopust, Amit Awasthi, Rémy Bosselut

|Sep 15, 2025
Lymphangiogenesis driven by VEGF-C reshapes tumor immune landscape and enables tumor eradication by viral immunotherapy.

Ruben Fernandez-Rodriguez, Sara Cuadrado-Castano, Andrew Edwards

|Nov 19, 2024
NOTCH1 Drives Sexually Dimorphic Immune Responses in Hepatocellular Carcinoma.

Katherine E Lindblad, Romain Donne, Ian Liebling

|Sep 30, 2024
ICOS limits memory-like properties and function of exhausted PD-1 + CD8 T cells.

Etienne Humblin, Isabel Korpas, Nataliya Prokhnevska

Pageof 3

Frequent Collaborators

6 joint publications

Etienne Humblin

5 joint publications

Verena van der Heide

4 joint publications

Abishek Vaidya

4 joint publications

Rafi Ahmed